Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
Craig is the founder/CEO of compliance operations software company Hyperproof and an expert in the compliance, risk, and technology space. In today’s volatile environment, organizations need to have ...
New Guardant Reveal offering provides oncologists with tissue-free solution to monitor treatment response and detect early disease progression with unprecedented speed and sensitivity Reveal is ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...
Our comprehensive Epilepsy Program delivers world-class care for epilepsy patients with state-of-the-art techniques and treatment approaches. U of U Health is one of only a few medical centers in the ...
Witbe has announced that it will showcase its powerful automated testing and proactive monitoring technology at the 2024 NAB Show. During the show the company will demonstrate the benefits of its ...
BAODING, HEBEI PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- In the rapidly evolving global power and energy ...
Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported. The paper-based KeepSight Journal from ...
The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy, the institute said. Epilepsy is a chronic brain disorder causing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results